/Investor DB

Seventure Partners — 2022 Investments

5 investments dated 2022 · listed companies and verified rows first · show all

BCD BioscienceinFeb 2022

BiotechDavis, US

Steven Watkins(Executive Officer, Director, Promoter)inCarlito Lebrilla(Director, Promoter)

Co-investorsArgonautic VenturesiSelect FundAcre Venture PartnersCollaborative FundLeaps by BayerMitsui & Co+1 more

Citalidcitalid.comin𝕏Oct 2022

Citalid provides a cyber risk quantification platform that translates cybersecurity threats and vulnerabilities into financial metrics and monetary impact assessments for enterprise decision-makers.

AI & Machine LearningCybersecurityEnterprise SoftwareInsurTechSaaSParis, FR

Maxime Cartan(Co-founder and CEO)inAlexandre Dieulangard(Co-founder and COO)

Co-investorsAxeleo Capital

Domain Therapeuticsdomaintherapeutics.comin𝕏May 2022 · $42M

Domain Therapeutics is a clinical-stage biopharmaceutical company developing GPCR-targeting therapies to address unmet medical needs in immuno-oncology and inflammation.

BiotechDigital Health

Co-investors3B Future Health FundCTI Life Sciences Fund L.P.adMare BioInnovationsOmnes CapitalPanacea Venture

Hardloophardloop.frinJan 2022

Hardloop is an online retailer selling outdoor and mountain sports equipment and technical apparel — including hiking, trail running, climbing, alpinism, cycling and camping gear — from a wide range of brands.

E-commerceRetail TechSports Tech

Julien JEREMIEin

Co-investorsKima Ventures

La Vielaviefoods.comin𝕏Jan 2022

La Vie Foods produces plant-based meat substitutes including bacon, ham, sausage, meatballs, sandwiches, and tofu for consumers seeking vegetarian and vegan alternatives.

BiotechConsumerFoodTechParis, FR

Nicolas Schweitzer(CEO)inVincent Poulichet(CTO)in

Co-investorsBleu CapitalCapagroEntrepreneur FirstOyster Bay Venture CapitalPartech VenturesZintinus+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.